Australia markets open in 1 hour 25 minutes

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.40000.0000 (0.00%)
At close: 04:00PM EDT
2.4000 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 104.67M
Enterprise value 142.07M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.02
Price/book (mrq)1.56
Enterprise value/revenue 1.40
Enterprise value/EBITDA 160.53

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-46.43%
S&P500 52-week change 330.69%
52-week high 35.5600
52-week low 32.3800
50-day moving average 32.8386
200-day moving average 33.6674

Share statistics

Avg vol (3-month) 3112.36k
Avg vol (10-day) 3124.55k
Shares outstanding 543.61M
Implied shares outstanding 644.88M
Float 838.22M
% held by insiders 17.77%
% held by institutions 173.73%
Shares short (13 Sept 2024) 4429.12k
Short ratio (13 Sept 2024) 44.67
Short % of float (13 Sept 2024) 41.06%
Short % of shares outstanding (13 Sept 2024) 40.98%
Shares short (prior month 15 Aug 2024) 4426.79k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21319:1000
Last split date 304 Nov 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -10.56%
Operating margin (ttm)-7.24%

Management effectiveness

Return on assets (ttm)-1.62%
Return on equity (ttm)-14.97%

Income statement

Revenue (ttm)101.12M
Revenue per share (ttm)2.35
Quarterly revenue growth (yoy)-19.70%
Gross profit (ttm)N/A
EBITDA 3.61M
Net income avi to common (ttm)-10.68M
Diluted EPS (ttm)-0.2500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.05M
Total cash per share (mrq)0.09
Total debt (mrq)41.45M
Total debt/equity (mrq)61.64%
Current ratio (mrq)2.05
Book value per share (mrq)1.54

Cash flow statement

Operating cash flow (ttm)9.22M
Levered free cash flow (ttm)11.31M